Researchers are working with schools around the county to find 24,000 volunteers aged 16 to 18 years to take part in the Be on the TEAM (Teenagers Against Meningitis) trial, led by the Oxford Vaccine Group at the Oxford University's Paediatrics Department with funding and support from the National Institute for Health Research (NIHR).
The Oxford Vaccine Group are inviting students in school year 12 to take part in a research project to understand whether immunising teenagers with vaccines against \u2018Meningitis B\u2019 could protect them and the rest of the community against these potentially deadly bacteria. This is a national study involving 24 000 year 12 students across the United Kingdom. Teenagers at participating schools are being asked to take part by local research teams involved.
Researchers from NDORMS, the Department of Oncology and Wellcome Centre for Human Genetics attend the Big Bang Fair 2018 to inspire the next generation of scientists.
Mildred Iro, a Paediatric Research Fellow working with the Oxford Vaccine Group, won the Lorber Prize for the best paediatric publication of 2017 for her work on childhood encephalitis admissions.
A new vaccine that could prevent up to nine-in-10 cases of typhoid fever has been recommended by the World Health Organization.\r\nBy James Gallagher, Health and science reporter, BBC News website
The Oxford Safer Pregnancy Alliance [OSPREA] and the Oxford Vaccine Group [OVG] have recently undertaken a successful recruitment drive for a study of maternal immunisation to prevent infant Respiratory Syncytial Virus [RSV] infection.
Hannah Robinson and Sarah Loving from the Department of Paediatrics were recognised in the annual awards hosted by the Thames Valley Clinical Research Network
Respiratory Syncytial Virus (RSV) is one of the most common reasons for young infants to be admitted to hospital, and globally is second only to malaria as a cause of death in infants between 1 and 12 months of age. In the UK it mostly occurs from October to February, causing a wave of infections that stretch the capacity of children\u2019s wards to their limits.
The Oxford Vaccine Group, part of University of Oxford, gave 99 volunteers a drink laced with live Salmonella Typhi bacteria a month after vaccinating them. Between 40% and 50% of the volunteers for the trial were students, Healthcare professionals were allowed to take part if they were not in patient-facing jobs or if they were willing to take around 3-4 weeks off work to be infected
The 12 winners of the inaugural University of Oxford's Vice-Chancellor\u2019s Awards for Public Engagement with Research were announced on Friday 1 July by the Vice-Chancellor, Professor Louise Richardson, in a ceremony at Merton College.
![\"\"](\"https://www.ovg.ox.ac.uk/news/oxford-vaccine-group-leads-meningitis-vaccine-trial-for-teenagers/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n